Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;20(5):294-307.
doi: 10.1038/s41577-019-0257-x. Epub 2020 Jan 27.

B cells, plasma cells and antibody repertoires in the tumour microenvironment

Affiliations
Review

B cells, plasma cells and antibody repertoires in the tumour microenvironment

George V Sharonov et al. Nat Rev Immunol. 2020 May.

Abstract

Recent data show that B cells and plasma cells located in tumours or in tumour-draining lymph nodes can have important roles in shaping antitumour immune responses. In tumour-associated tertiary lymphoid structures, T cells and B cells interact and undergo cooperative selection, specialization and clonal expansion. Importantly, B cells can present cognate tumour-derived antigens to T cells, with the functional consequences of such interactions being shaped by the B cell phenotype. Furthermore, the isotype and specificity of the antibodies produced by plasma cells can drive distinct immune responses. Here we summarize our current knowledge of the roles of B cells and antibodies in the tumour microenvironment. Moreover, we discuss the potential of using immunoglobulin repertoires as a source of tumour-specific receptors for immunotherapy or as biomarkers to predict the efficacy of immunotherapeutic interventions.

PubMed Disclaimer

References

    1. Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348, 69–74 (2015). - PubMed - DOI - PMC
    1. Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486–499 (2015). - PubMed - PMC - DOI
    1. Wei, S. C. et al. Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade. Cell 170, 1120–1133 (2017). - PubMed - PMC - DOI
    1. Borst, J., Ahrends, T., Babala, N., Melief, C. J. M. & Kastenmuller, W. CD4+ T cell help in cancer immunology and immunotherapy. Nat. Rev. Immunol. 18, 635–647 (2018). - PubMed - DOI - PMC
    1. Schoorl, R., Riviere, A. B., Borne, A. E. & Feltkamp-Vroom, T. M. Identification of T and B lymphocytes in human breast cancer with immunohistochemical techniques. Am. J. Pathol. 84, 529–544 (1976). - PubMed - PMC

Publication types

MeSH terms

LinkOut - more resources